ApprovalTrail

Approval · Notice of Compliance 23958 · 2020

STALEVO: Notice of Compliance 23958

Issued July 24, 2020

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
23958
Date
July 24, 2020
Company
Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Administrative: Change in Product Ownership

Products in this notice

BrandDINStatus today
STALEVO02305933Marketed
STALEVO02305941Marketed
STALEVO02305968Marketed
STALEVO02337835Marketed
STALEVO02337827Marketed

Medicinal ingredients